Douglas Ross - Dec 21, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Former CSO
Signature
/s/ Douglas Ross
Stock symbol
OCX
Transactions as of
Dec 21, 2022
Transactions value $
$0
Form type
4
Date filed
12/22/2022, 05:57 PM
Previous filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $0 +214K +1052.31% $0.00 234K Dec 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest as follows: (i) one-third on January 31, 2023, (ii) one-third on February 28, 2023, and (ii) one-third on March 31, 2023 (each such date, a "Vesting Date"), in each case, subject to the Reporting Person's continuous service as a consultant on each applicable Vesting Date.